As of the start of this week, police forces and local authorities have new legal powers designed to reduce the number of dog attacks.
For the first time, police and local authorities will be able to demand that owners take action to prevent a dog attack or risk fine of up to £20,000. If a complaint has been made about a dog to the council or police, its owners can be ordered to do any or all of the following:
The government has published a manual called Dealing with irresponsible dog ownership: practitioner's manual, to guide police forces and local authorities in the use of their new legal powers to prevent dog attacks.
Animal Welfare Minister Lord de Mauley said: "Dog attacks are devastating for victims and their families which is why we are taking tough action against those who allow them to happen. Police and local authorities will now have more powers to demand that irresponsible dog owners take steps to prevent attacks before they occur. This is on top of the tougher prison sentences we introduced earlier this year for owners who allow their dogs to attack people and assistance dogs."
The National Policing Lead for Dangerous Dogs, DCC Gareth Pritchard said: "The Practitioners Manual gives police officers and other practitioners clear guidance on how to best implement the legislative changes, especially the early preventative measures such as Community Protection Notices, to help prevent more serious events occurring in the future. It also provides a platform to share good practice between police forces and partner agencies and it will form part of the ongoing training of Dog Legislation Officers across England and Wales."
Photo credit: iStockphoto/Thinkstock.
Elanco Animal Health has launched AviPro Salmonella Duo, a new live vaccine which provides simultaneous protection against S Enteritidis and S Typhimurium in poultry.
Jessica Cross, Elanco's poultry veterinary consultant said: "AviPro Salmonella Duo is the first vaccine to have both Salmonella strains in the same vial and also the first to be licensed for turkeys and ducks as well as chickens."
Unlike inactivated vaccines which are administered by injection, AviPro Salmonella Duo is administered in the drinking water. Elanco says this offers producers significant advantages since the oral route allows mass administration without stressing the birds, saving labour and improving welfare. A three-dose programme provides immunity throughout lay.
The new vaccine also provides an eight-week increase in the period of immunity over its predecessor, to 62 and 68 weeks of age for S Typhimurium and S Enteritidis respectively.
Jessica said: "This development represents the third generation of vaccines, moving on from the early dead vaccines, individual live vaccines to the bivalent product. Producers will welcome the simplified administration it offers."
Merial has joined forces with the Global Alliance for Rabies Control (GARC) promote its "Me and My Dog - Together Against Rabies" social media campaign, designed to raise awareness of the importance of vaccinating dogs against rabies.
As part of the campaign, pet owners are asked to share photos of themselves with their dog on social media channels, using the hash tags #TogetherAgainstRabies and #MerialMeAndMyDog.
Merial says the increased numbers of pets travelling since the changes to the Pet Travel Scheme rules in 2012 means that awareness of rabies amongst pet owners is important, despite the fact that the disease is not endemic in the UK.
Joanne Maki, Director Veterinary Public Health for Wildlife and Companion Animals for Merial said: "The "Me and My Dog - Together against Rabies" campaign is a unique opportunity for all of us to play a part in spreading the word about eliminating human rabies through the vaccination of animals. The more of us who participate, the stronger we are in this important fight".
Virbac has announced the launch of what it describes as an affordable ciclosporin for the treatment of canine atopic dermatitis.
Called Cyclavance, the new product will make its debut at the London Vet Show (Nov 20th/21st at London Olympia).
Cyclavance is presented in a liquid formulation for precise dosing, in a container with a new 'AdaptaCap' designed to ensure leak proof dispensing and give the product a 6 month shelf life after being broached. Cyclavance is offered in four size presentations - 5 ml, 15 ml, 30 ml and 50 ml - to give practices maximum flexibility in its use.
Sarah Walker MRCVS, Product Manager, said: "Atopic dogs present at practices across the country on a daily basis. It is a challenging condition which can be hard to treat successfully because owner compliance is so important. By offering Cyclavance at a great price to give greater appeal, allowing a wider scope of use, and with innovative features, such as the unique AdaptaCap, we aim to help practices achieve better outcomes for their patients and increase the number of clients it is available to.
Boehringer Ingelheim Vetmedica has launched Equisolon 33 mg/g oral powder, the first licensed oral prednisolone for the alleviation of inflammation associated with recurrent airway obstruction (RAO), otherwise known as heaves, in horses.
Clare Turnbull, equine brand and technical manager at Boehringer Ingelheim Vetmedica said: "Oral glucocorticoids are sometimes necessary for treating the inflammation associated with RAO. We feel it is important that when our customers need to use prednisolone for their cases, there is an equine specific product available to them that is easy to dispense and administer."
The company says Equisolon should be used in combination with environmental measures to treat RAO.
For further information on Equisolon, contact your Boehringer Ingelheim Vetmedica equine representative or call +44 (0)1344 746959.
Following ongoing lobbying by the British Veterinary Association and others, the Veterinary Medicines Directorate has dropped controversial plans for a new veterinary medicines category - POM EA (prescription-only medicine extended administration).
The proposed category has been discussed at the Veterinary Products Committee (VPC) since 2009. The original purpose was to provide a new category under which a veterinary surgeon would make a clinical assessment and, if appropriate, issue a Veterinary Permission of Extended Administration (VPEA) allowing the animal holder to obtain the prescribed POM EA medicine (from a veterinarian, pharmacist or SQP) for up to 36 months from the date of authorisation.
The BVA, along with its specialist divisions, says it opposed POM EA from the outset and failed to see that there was any justification for a new category. Veterinary surgeons are already able to write prescriptions for extended use and, as most health plans are reviewed annually, anything beyond a yearly assessment would be unacceptable on health and welfare grounds. An additional category would have also taken the UK even further out of step with the rest of the EU.
The BVA submitted written comments and attended a stakeholder meeting with the VMD to discuss concerns. Despite the VMD suggesting revisions to the original proposal the BVA and other stakeholders maintained that the new category was unnecessary.
Following these consultations, the VPC decided, at a meeting in March, not to progress the proposal any further.
Harvey Locke, President of the BVA, said: "We are extremely pleased that the Veterinary Products Committee has listened to our concerns and decided to drop its plans for POM EA.
"The BVA felt strongly that the proposed new category was unnecessary at best and potentially harmful to animal health and welfare at worst.
"In all fields of practice veterinary surgeons would not feel comfortable prescribing for such long periods without regular contact with the animals they care for."
The Royal College of Veterinary Surgeons Council and the Veterinary Nursing Council have decided that there will be no increase in registration and retention fees for veterinary surgeons and veterinary nurses for 2012.
Last year, the Councils decided that a lower than inflation increase should apply to fees for 2011 to help mitigate the impact of the difficult economic climate on veterinary surgeons and veterinary nurses. Members who are over 70 and who cease practising do not have to pay fees if they wish to remain on the Register.
Bradley Viner, RCVS Treasurer said: "We know times are tough financially for many people and hope that freezing fees will help a little. Professional regulation can be costly, but we try to keep fees as low as possible."
The RCVS financial policy remains that fee increases should be small and incremental in order to avoid a need for periodic sharp fee hikes resulting from inflationary pressures.
Fees for 2012 will be as follows:
2012 fees (£)
Veterinary surgeons
UK-practising retention fee
299
Overseas-practising retention fee
150
Non-practising retention fee
49
Non-practising retention fee (over 70 years old)
0
Registration fee
Temporary registration fee
Restoration fee
Restoration fee following voluntary removal
75
Veterinary nurses
Retention fee
61
Boehringer Ingelheim Vetmedica has increased its range of marketing and educational materials about heart disease and the use of Vetmedin.
The materials include canine heart disease awareness posters for either the waiting room or consult room which feature 'static cling' technology, enabling them to stick to any surface without adhesive, as well as information leaflets, owner booklets, health diaries and dog tags.
Materials for dog owners are designed to inform about the signs to look out for with heart disease, and the steps involved in the diagnosis and management of the condition. There's a post-prescription owner booklet which features a health diary for dog owners to fill in, allowing them to track any changes in their dog's condition, as well as details on the telltale signs of heart failure and the benefits of Vetmedin.
Also available in the range are materials to help make prescribing the optimum dose of Vetmedin as easy as possible, including dose optimisation mouse mats, dose dials, treatment algorithms and interactive dose calculators on CD for those veterinary practices without internet access.
For further information, please contact your Boehringer Ingelheim Vetmedica territory manager or call 01344 746959.
Defra has announced that Great Britain is to be declared bluetongue-free from 5th July 2011.
From this date, bluetongue susceptible species being exported from Great Britain will no longer need to be vaccinated against BTV8 or meet any of the other 'Annex III conditions.
However, the current EU Bluetongue Directive only allows bluetongue vaccination within a protection zone, so from 5th July vaccination will no longer be permitted in Great Britain.
The British Veterinary Association is supporting Defra to lobby for these rules to be changed to allow vaccination in bluetongue areas.
Harvey Locke, BVA President, said: "The move to bluetongue freedom is thanks to the excellent partnership between government, farmers and vets across Great Britain. It is a tremendous achievement to turn the situation around from the outbreak in 2007 to freedom in 2011.
"We are disappointed that changes to the EU Directive to allow vaccination to continue could not be made before the deadline and we will continue to work with Defra to try to secure this change as soon as possible to allow vets and farmers to make the right choice to protect their herds.
"Those farmers and vets that wish to vaccinate must do so before the 5th July.
"The BVA would reiterate the message to farmers to source stock responsibly to help avoid a future outbreak."
RCVS Day - the Royal College of Veterinary Surgeons Annual General Meeting and Presentation of Awards - will be held on Friday 1 July 2011 at One Great George Street, London.
All members and listed/registered veterinary nurses are invited to attend the day, which will start at 10am with AGM business, followed by the celebration of veterinary and veterinary nursing achievements. Professor Soraya Shirazi-Beechey will be receiving her Honorary Associateship and Dr James Kirkwood and Des Thompson will be accepting their Honorary Fellowships.
A new award to mark the 50th anniversary of veterinary nursing will also be presented, as well as a Lifetime Contribution Award from the RCVS Charitable Trust.
In his last official engagement as President, Peter Jinman will give a review of his year before formally welcoming new Council and VN Council Members, and Dr Jerry Davies to the role of President for 2011-2012.
To celebrate Vet2011, the RCVS is honoured to announce that there will be two guest speakers this year - Dr Christophe Buhot DVM and Professor Gary England FRCVS, who will deliver a talk about the history and future direction of veterinary education.
For tickets, which are free and allocated on a first-come, first-served basis, please contact Fiona Harcourt at the RCVS on f.harcourt@rcvs.org.uk or 020 7202 0773.
Intervet/Schering-Plough Animal Health has announced that it has received approval for the intramuscular (IM) route of administration of Nuflor Minidose 450 mg/ml, a florfenicol-containing broad-spectrum antibiotic for the management of bovine respiratory disease (BRD).
Nuflor Minidose was approved initially in 2008 for subcutaneous (SC) use only and the now approved IM administration route is a line extension. According to Intervet/Schering Plough, IM administration (20 mg/kg administered twice, 48h apart) offers additional flexibility for the veterinary surgeon when treating cattle for BRD.
The company adds that Nuflor Minidose is the florfenicol injectable formulation which offers the lowest injection volume, which in particular is practical when treating heavier animals (thereby avoiding large injection volumes). The withdrawal period after IM administration of NUFLOR Minidose is only 37 days and is considerably shorter as compared to 64 days after SC use (40 mg/kg body weight injected once).
Francis Adriaens, Global Marketing Director, Global Ruminants Business Unit at Intervet/Schering-Plough Animal Health said: "Our customers requested the IM claim when Nuflor Minidose was first introduced and we are delighted to be able to recommend this route of administration hence forth."
Nuflor Minidose is indicated for preventive and therapeutic treatment of BRD in cattle caused by Mannheimia haemolytica, Pasteurella multicoda and Histophilus somni susceptible to florfenicol. The presence of the disease in the herd should be confirmed before administering preventive treatment.
The World Small Animal Veterinary Association has established a new Foundation with a remit to improve global companion animal care through science and education.
The WSAVA Foundation, a not-for-profit body, is now identifying a range of potential projects, which it says are likely to include:
It is also identifying sources of funding, grants and partnerships with the veterinary pharmaceutical and pet nutrition sectors and other potential donors.
Dr Larry Dee, WSAVA Foundation President, former WSAVA President and co-owner of a large companion animal practice in Florida, said: "The creation of this new Foundation is one of the WSAVA's most exciting initiatives to date. We have an ambitious vision to improve global companion animal care through science and education.
With its establishment, global veterinary medicine now has a wonderful opportunity to utilize the networking resources and global 'connectivity' of WSAVA to deliver on its goal of improving companion care everywhere. We will be announcing details of our first initiatives shortly."
For further information on the WSAVA Foundation, please contact the WSAVA Secretariat at wsavasecretariat@gmail.com.
Abbott Animal Health has announced the launch PropoFlo Plus, a 28-day preserved version of propofol intravenous anaesthetic for use in dogs and cats.
PropoFlo Plus contains benzyl alcohol, an antimicrobial preservative that provides it with a shelf life of 28 days, once opened. PropoFlo Plus is indicated for therapeutic use as a short-acting, intravenous general anaesthetic with a short recovery period. PropoFlo Plus can be used for procedures of a short duration, lasting up to approximately five minutes, and for induction of general anaesthesia where maintenance is provided by inhalation anaesthetic agents. Abbott says the extended shelf life of PropoFlo Plus provides an option for practices that may not routinely use an entire bottle of unpreserved propofol.
Jeff Schaffnit, Senior Director of Global Sales, Marketing and Business Development, Abbott Animal Health said: "Many veterinary surgeons are rightfully concerned about ways to save on costs and reduce waste in their practices, including anaesthetic waste. PropoFlo Plus is designed to minimise waste while providing veterinary surgeons with the confidence of using a familiar, trusted anaesthetic."
Abbott says that in addition to an extended shelf life, PropoFlo Plus provides the same established performance of PropoFlo, including:
The company also claims that studies show administering PropoFlo Plus results in no pain on injection.
PropoFlo Plus is available now through veterinary wholesalers. Abbott says it will be providing expert product support for PropoFlo Plus through local representatives, anaesthesia consultants and training tools for staff.
It's the final call for comments on the draft new RCVS Code of Professional Conduct for Veterinary Surgeons, as the consultation closes on Friday, 24 June 2011.
The new draft Code, which is intended to replace the existing RCVS Guide to Professional Conduct for Veterinary Surgeons, was produced by a Working Party set up by the RCVS Advisory Committee.
The new Code is a short, principles-based document using the Federation of Veterinarians of Europe's Code of Conduct as the starting point. It will be supported by additional advice on specific areas of veterinary practice or issues, for example, clinical governance.
New requirements in the Code include compulsory continuing professional development, the RCVS Health Protocol and more on clinical competence. It also contains an updated declaration to be made by veterinary surgeons, which gives increased emphasis to animal welfare.
The new Code, together with the consultation paper, can be downloaded at www.rcvs.org.uk/codeconsultation.
Comments, which are welcomed from the profession and the public, should be sent by email to Christopher Murdoch, Secretary to the Guides Review Working Party, at c.murdoch@rcvs.org.uk by Friday, 24 June 2011.
A separate consultation will open shortly on a draft RCVS Code of Professional Conduct for Veterinary Nurses.
According to a survey carried out by Pfizer, veterinary surgeons are generally upbeat about the business prospects for their practice this year, despite predicting a harsh economic environment for the industry as a whole in 2011.
The Pulse Survey of more than 400 practice owners and their senior management teams, which presents a snapshot of market sentiment, revealed that predictions for the veterinary market in general remained as gloomy as 2010. Over half (52%) of respondents believed that conditions for the industry would get more challenging.
However, the response from owners about their own practice's performance was more bullish with a third (34%) believing their prospects will improve.
Pfizer Business Consultant, James White, said: "Practices are right to remain cautiously optimistic about 2011 if we accept it's going to be a challenging year. Some practices came slightly unstuck in 2010 as a result of the knock-on effects of the economic downturn on pet owners' pockets. However, by implementing the correct strategies now there are still opportunities for growth. Client loyalty is the buzz word and should remain a key component of any practice strategy being implemented in the coming months."
Pfizer launched the Pulse survey in Autumn 2010 to deliver up to date analysis on a range of issues that senior management teams at practice level are witnessing. According to the company, the survey is attracting a growing volume of respondents. All participants receive a summary report of the Pulse Survey findings.
Pfizer's team of Business Consultants is working with practices throughout the country to pinpoint their individual business challenges, offer solutions through the company's Vet Support+ service and work with the practices to drive growth. For further information visit http://www.vetsupportplus.co.uk/.
The National Office of Animal Health has completed its annual review of its Code of Practice for the Promotion of Animal Medicines, and a number of changes will come into effect on 1st July 2011.
One change spells out the way antimicrobial medicines are promoted to farmers, with a firm emphasis on correct use and education.
Advertisers will be required to describe the condition the product is aiming to treat, and to promote an understanding of the treatment of the disease.
The phrase "use medicines responsibly" will always be included in text, making the voluntary strapline introduced in 2009 a formal part of the NOAH Code. As with all promotions to people other than prescribers, farmers will always be reminded to consult their veterinary surgeon.
Advertising text will always state clearly the name of the company and the brand being promoted, and promotion must not be designed to disguise its real nature.
Withdrawal periods for products will be stated, but these must not be unduly prominent and not in a font size greater than the body copy containing recommended dosage and species description.
The changes were proposed by NOAH within its formal response to the Veterinary Medicines Directorate's consultation on the Veterinary Medicines Regulation 2010. The Minister decided in December 2010 to continue to allow the advertising of antimicrobial veterinary products to farmers.
Phil Sketchley, NOAH Chief Executive, said: "Whilst welcoming the Government's decision in December not to further restrict the advertising of animal medicines, we feel that the industry should take a proactive role to ensure the system works properly. We believe it is important for farmers, who are legally responsible for the health and welfare of their animals and the food produced from them, to be aware of the medicines that are available to protect the health of their animals, and at the same time we want them to know that these medicines must be prescribed and used responsibly.
"The issue of antimicrobial resistance is one that affects us all. The way to promote best practice is through education by maintaining all lines of communication between farmers, vets, scientists and animal medicine producers.
"Antibiotics are essential for maintaining the health and welfare of all animals, but like any medicine they need to be used responsibly in order to maintain their effectiveness, and their availability for future generations."
Royal Canin is to launch a hepatic diet for cats.
Available from July 2011, Royal Canin Hepatic Feline is designed to provide nutritional support to the cat post-surgery and throughout a wide range of clinical conditions including cholangitis, cholestasis, portosystemic shunts, hepatic encephalopathy, liver failure and hepatic copper accumulation.
Royal Canin says the diet includes the use of highly digestible vegetable proteins which reduce the workload of the recovering liver; low copper levels to help reduce the risk to the liver of damage caused by copper and bile interaction; an exclusive antioxidant complex to neutralise free radicals, and balanced mineral levels to help counteract electrolyte imbalances caused by liver disease.
The company also says Royal Canin Hepatic Feline is 'outstandingly palatable', making it much easier for the cat (and the owner) to adhere to the regime.
Royal Canin Hepatic Canine is also available in both wet and dry versions. For more information, contact your Royal Canin Veterinary Business Manager, call 0845 717 800, or visit http://www.royalcanin.co.uk/.
Vets are being asked to help pig producers assess their health status and biosecurity measures, as part of BPEX's new National Pig Health Improvement Project (PHIP).
The national programme is currently running alongside existing programmes in East Anglia, Yorkshire and the East Midlands and will cover all the remaining regions. BPEX will now start to combine all programmes into the National PHIP. So all English pig producers and vets can join the industry-wide drive to improve pig health and reduce costs.
BPEX says the national Pig Health Improvement Project (PHIP) project will need the support of veterinary surgeons to:
BPEX regional health coordinator Helen Clarke said: "The surveys are filled in by vets during quarterly farm visits to gather information on prevalence of four key diseases - swine dysentery, PRRS, enzootic pneumonia and mange. This is then used to populate a confidential online mapping service, which PHIP members can use to keep informed of health challenges in their area.
"The biosecurity audit is a series of simple to answer questions about current biosecurity practice of a unit. This then forms the basis for biosecurity planning and discussions to help clients make improvements and review their impact."
A further benefit when producers sign up to the PHIP is free-of-charge post-mortem information from the BPEX Pig Health Scheme (BPHS). The BPHS provides producers with detailed post-mortem health reports when they submit pigs to participating abattoirs.
Clients who are:
Practices can claim £50 per unit for completing the survey and biosecurity audits. This still needs to be claimed through specific regional systems because of current funding contracts.
Contact Helen Clarke for details: helen.clarke@bpex.ahdb.org.uk or 07973 701369. Visit http://www.pighealth.org.uk/
Novartis Animal Health has launched its Summer Worming Packs.
The packs are part of an ongoing campaign by the company to get pet owners to worm their animals at least 4 times a year (as recommended by the European Scientific Counsel Companion Animal Parasites1), as opposed to the current norm of 2.6 times per year2.
The Summer Worming Packs include waiting room and client materials, and practice PR support materials. There is also a pet owner website http://www.wormpatrol.co.uk/.
For further details about the Summer Worming Pack or the Worm Patrol Campaign, veterinary practices should contact their Novartis Animal Health Territory Manager.
The Disciplinary Committee of the Royal College of Veterinary Surgeons has dismissed a case against a Staffordshire veterinary surgeon, having found that his convictions under the Criminal Justice Act 1988 and the Public Order Act 1986 did not make him unfit to practise veterinary surgery.
At the one-day hearing, the Committee heard that Mr Richard Conlon of Warrendale Veterinary Care Centre, Biddulph, was convicted of one instance of common assault and one public order offence involving threatening, insulting or abusive language, both of which occurred during an altercation in a public house in Biddulph on 28 November 2009. The court ordered Mr Conlon to pay two fines of £300 each, a victim surcharge of £15, and £700 of court costs.
As the facts involved in Mr Conlon's offences had been proved by the court that convicted him, and Mr Conlon admitted to his convictions, the Committee considered only whether these offences made him unfit to practise veterinary surgery.
The Committee was advised that although the convictions were unrelated to Mr Conlon's professional practice, any criminal conviction may call into question a veterinary surgeon's fitness to practise if the conduct for which they are convicted raises doubts over their capability as a veterinary surgeon. Convictions that damage the wider public interest in the good reputation of the profession and public confidence can also raise questions about fitness to practise and may be considered.
Speaking on behalf of the Disciplinary Committee, Vice-Chairman Professor Sheila Crispin said: "In reaching our decision, it is important to emphasise that the Disciplinary Committee does not condone Mr Conlon's behaviour in any way. We accept the submission of the College 'that it is incumbent on any veterinary surgeon to act with decorum and not to engage in any violent, aggressive or intimidating behaviour,' and, on any view, for a veterinary surgeon to get involved in a brawl in a public house is unacceptable behaviour.
"In the Committee's judgment this was a one-off incident of brief duration with no premeditation on Mr Conlon's part; fortunately no significant injury was suffered by anybody involved. From the nature of the charges and the sentence of the court, it can be seen that this was at very much the lower end of seriousness and, as is accepted by the College, involves no concern about Mr Conlon's ability to practise as a veterinary surgeon."
The Committee ordered the charges be dismissed.
Two new Postgraduate Deans have been appointed by the Royal College of Veterinary Surgeons to advise and monitor new veterinary surgeons during their Professional Development Phase (PDP), the first stage in veterinary continuing professional development.
Jill Hubbard, a partner at Cibyn Veterinary Surgery, Caernarfon, and organiser of BVA North Wales' young graduate meetings, and Nicky Paull, a former BVA President with extensive experience of running veterinary practices and understanding of the needs of veterinary graduates, were selected from over 40 applicants. They join existing Deans, Professor Agnes Winter and Julian Wells, and replace Professor David Noakes and Stephen Ware, who are retiring from the role having served since 2007, when PDP first became a requirement for veterinary graduates.
Jill Hubbard said: "I have always had a particular interest in how we support and guide our new graduates. This seemed a way of being actively involved - a useful niche to try and fill."
Nicky Paull said: "The development of young veterinary graduates has been of special interest to me for some years. In employing young veterinary surgeons, meeting recent graduates through my political work and the time spent with undergraduates through extra-mural studies and the Society of Practising Veterinary Surgeons' final year student seminars, I'm aware of the need for help and guidance for development of the young vets who are joining our profession."
The PDP applies to every newly qualified veterinary surgeon. It consists of an online record which the vet completes, and which is signed off by a Postgraduate Dean. This helps new vets and their employers check that sufficient experience is being gained so that the vet can progress from the 'Day-One competencies' of a new graduate to those expected of a vet with about a year's in-practice experience.
Merck has announced that its animal health division, formerly known as Intervet/Schering-Plough, has changed its name to MSD Animal Health in countries outside the United States and Canada from today.
Intervet/Schering Plough will now be known as Merck Animal Health in the United States and Canada.
Raul Kohan, President of Merck Animal Health said: "The name change reflects Merck's commitment to animal health and its complementary role to the overall business. We are unwavering in our commitment to veterinarians, producers, pet owners and society as a whole. We aim to generate additional value and sustained growth by continuing to provide integrated solutions with innovative animal health products and services to meet the evolving needs of our customers."
Mr. Kohan continued: "With the scientific and business backing of Merck, Merck Animal Health possesses the necessary mix of resources to enhance our position as an industry leader."
Merck says it values the diversification that Merck Animal Health brings to its portfolio, and sees growth opportunities in the business that can be leveraged across both animal and human health. The company intends to capitalize on Merck Animal Health's broad and innovative portfolio going forward, and to develop the unit into a best-in-class global animal health leader.
The name change follows the joint announcement on March 22, 2011 by Merck and sanofi-aventis that ended plans to form a new animal health joint venture. Both companies mutually decided to discontinue their agreement primarily because of the increasing complexity of implementing the proposed transaction.
Vetoquinol UK Ltd is launching a dedicated large animal/equine sales force on the 1st July.
The company says the move reflects the change in cattle and equine veterinary practice to become specialists.
Vetoquinol's large animal brands include: Marbocyl®, Sedalin®, Equistro®, Tolfine®, Pro Rumen and Locatim®.
The new team comprises:
The new sales team will be managed jointly by Hugh Gibson and Stuart Wade.
For further information or to make an appointment please contact your local Territory Manager direct or telephone 01280 825424
Dechra Veterinary Products has added to its Veterinary Essentials range of veterinary-licensed post-patent products with the launch of Fiprocat and Fiprodog, a fipronil spot-on solution for the treatment and prevention of on-animal flea infestations in cats and dogs.
Available in packs of 3 or 6 pipettes, Fiprocat and Fiprodog are only distributed through the veterinary channel. Dechra highlights the product's convenient self-standing pipette. which it says makes the process of applying the spot-on easier.
Dechra says it offers a wealth of client support material, and practice promotional support to go with the product.
Fiprocat and Fiprodog can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis (FAD).
Rob Simpson at Dechra said: "Fipronil has been used in the treatment and prevention of on-animal flea infestations for many years and is one of the most commonly used treatments in practice. Fiprocat and Fiprodog join R.I.P Fleas Extra to offer a cost effective complete flea solution to tackle both on-animal and environmental flea infestations."
Petplan has launched a new look policy range to give pet owners more comprehensive cover and make it easier for them to understand the types of cover available.
Simon Masding, Petplan's Head of Sales and Partnerships said the refreshed policies will not only benefit the pet and their owner but the changes will also allow veterinary staff to explain the policies with a lot more clarity: "Since Petplan started 35 years ago the pet insurance market and vet industry has changed significantly, especially in the last few years. There are now over 250 policies in the market with varying benefits and levels of cover, which often confuses customers to a point where they think they're getting lifetime cover but they're instead trapped with a restrictive policy.
"The veterinary industry is also continually changing with advances in new technology and better diagnostics allowing the industry to save and treat more pets, which means our policies need to evolve with them."
To better understand these changing market dynamics, Petplan held focus groups with veterinary staff from across the UK and undertook extensive research with charities, breeders, customers and non-customers.
Apparently, the feedback showed that Petplan needed to communicate its range of policies more clearly, to shift away from the confusion created by other brands and meet the changing demands of the vet industry and pet owners better.
For this reason, Petplan says it has simplified its policy range, adding and increasing each policy's benefits, making a 12 month policy available for practices to offer, and developing easy-to-understand policy names.
Petplan's new look policies for both cats and dogs are:
Petplan says its Covered for Life policies, Petplan Ultimate and Petplan Classic, will continue to provide pet owners with the best cover in the market. However, the company recognises that these policies are not always suitable for people with older pets or a limited budget.
Simon said: "Petplan Essential, our 12 month policy, will also now be available for veterinary staff to offer to their customers. While our Covered for Life Ultimate and Classic will continue to be our leading policies and at the heart of what we do, it's better that a pet owner has some type of cover rather than nothing at all and Essential is a market leading 12 month policy."
Zeta Frasca, practice owner and vet at Kitten to Cat in Richmond London said: "These changes will not only make it clearer for the pet owner but it will also make it a lot easier for us as an industry to explain pet insurance to our clients, which is really important."
For more information about Petplan's new look policies visit www.petplan.co.uk, call their dedicated Vetline on 0800 3168 8900 or talk to your Petplan Business Developer.
The following table outlines each policy and its benefits: